Notably, attention is growing within the UK regarding this peptide as a potential therapy for metabolic complications. While largely emerging , knowledge of its potential benefits – particularly in alleviating the effects of HIV-related lipodystrophy – is gaining. Specialists are researching its suitability, and patient demand is increasing ,